Figure 5From: BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition Duration of viremia under different treatment strategies (Figure 5 A; * = 1 patient with ongoing low level viremia, † = three patients transplanted in 2011 with ongoing low level viremia, ‡ = 2 patients started dialysis prior to viral clearance). Peak viral load under different treatment strategies ( Figure 5 B). Change in serum creatinine between onset and clearance of BK viremia under different treatment strategies ( Figure 5 C; * = patients with ongoing low level viremia; ‡ = 2 patients that commenced dialysis prior to viral clearance). Change in albuminuria between onset and clearance of BK viremia under different treatment strategies ( Figure 5 D ). Mean values are presented above each symbol.Back to article page